Show simple item record

dc.contributor.authorYAZICI, Halil
dc.contributor.authorTÜRKMEN, Aydın
dc.contributor.authorKaya, Omer
dc.contributor.authorYelken, Berna
dc.contributor.authorAlpay, Nadir
dc.contributor.authorAkagun, Tulin
dc.contributor.authorCaliskan, Yasar
dc.date.accessioned2022-02-18T09:44:42Z
dc.date.available2022-02-18T09:44:42Z
dc.date.issued2011
dc.identifier.citationAkagun T., Caliskan Y., Kaya O., YAZICI H., Yelken B., Alpay N., TÜRKMEN A., "Immunosuppressive Agents in the Treatment of Membranoproliferative Glomerulonephritis", TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.20, sa.2, ss.173-177, 2011
dc.identifier.othervv_1032021
dc.identifier.otherav_5a02bb74-3547-4ed2-b64f-cbdcd33121ea
dc.identifier.urihttp://hdl.handle.net/20.500.12627/177880
dc.identifier.urihttps://doi.org/10.5262/tndt.2011.1002.10
dc.description.abstractINTRODUCTION: Treatment of membranoproliferative glomerulonephritis (MPGN) is often unrewarding with approximately 60% of patients progressing to end-stage renal failure within 10 years. In our study, we compared the efficacy of CS alone versus low dose CS + another immunosuppressive agent retrospectively. MATERIAL and
dc.language.isoeng
dc.subjectNefroloji
dc.subjectNephrology
dc.subjectUrology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleImmunosuppressive Agents in the Treatment of Membranoproliferative Glomerulonephritis
dc.typeMakale
dc.relation.journalTURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
dc.contributor.departmentİstanbul Teknik Üniversitesi , ,
dc.identifier.volume20
dc.identifier.issue2
dc.identifier.startpage173
dc.identifier.endpage177
dc.contributor.firstauthorID3378401


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record